SARS-CoV-2/Human/USA/SC-CDC-LC1046921/2023
SARS-CoV-2: clinical or host-associated
BioSampleModel
2023-08-02T01:45:54Z
ENA-FIRST-PUBLIC
2023-08-02T01:45:54Z
ENA-LAST-UPDATE
SAMN36776480
External Id
CDC-OAMD
INSDC center name
2023-08-02T01:45:54Z
INSDC first public
2023-08-02T01:45:54Z
INSDC last update
public
INSDC status
SARS-CoV-2/Human/USA/SC-CDC-LC1046921/2023
Isolate
SRS18460673
SRA accession
SARS-CoV-2/Human/USA/SC-CDC-LC1046921/2023
Submitter Id
NCBI
broker name
Laboratory Corporation of America
collected_by
2023-07-20
collection_date
Nasal Swabs
collection_device
Nasal Swabs
collection_method
N1 gene
diagnostic_gene_name_1
N2 gene
diagnostic_gene_name_2
RP gene
diagnostic_gene_name_3
24.235
diagnostic_pcr_Ct_value_1
21.509
diagnostic_pcr_Ct_value_2
36.319
diagnostic_pcr_Ct_value_3
Labcorp LDT
diagnostic_pcr_protocol_1
Labcorp LDT
diagnostic_pcr_protocol_2
Labcorp LDT
diagnostic_pcr_protocol_3
USA: South Carolina
geo_loc_name
Homo sapiens
host
63
host_age
COVID-19
host_disease
Unknown
host_race
male
host_sex
Nasal Swabs
isolation_source
XBB.1.16.6
lineage/clade name
Severe acute respiratory syndrome coronavirus 2
organism
baseline surveillance (random sampling)
purpose_of_sequencing
Severe acute respiratory syndrome coronavirus 2
scientific_name
CDC Sars CoV2 Sequencing Baseline Constellation
title